Spectranetics Corp.: FDA filings under this applicant name
FDA lists 43 510(k) clearances under 5 spellings of the applicant name “Spectranetics Corp.” (first 1999, latest 2025), plus 4 PMA and 1 De Novo decisions, across 11 product codes in 1 review panel. Median 510(k) review time under this name: 79 days. Since 2017 the median was 79 days, against 102 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Philips, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 1 | 63 |
| 2014 | 6 | 56 |
| 2015 | 3 | 29 |
| 2016 | 2 | 58 |
| 2017 | 3 | 91 |
| 2018 | 1 | 20 |
| 2019 | 0 | — |
| 2020 | 1 | 20 |
| 2021 | 0 | — |
| 2022 | 3 | 79 |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 1 | 30 |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Spectranetics Corp. took a median 79 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 102 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| DQY | Catheter, Percutaneous | 11 | 11 |
| MCW | Catheter, Peripheral, Atherectomy | 10 | 10 |
| DRE | Dilator, Vessel, For Percutaneous Catheterization | 9 | 9 |
| PDU | Catheter For Crossing Total Occlusions | 7 | 7 |
| DRB | Stylet, Catheter | 3 | 3 |
| LPC | Device, Angioplasty, Laser, Coronary | 2 | 0 |
| MJN | Catheter, Intravascular Occluding, Temporary | 2 | 2 |
| NWX | Catheter, Percutaneous Transluminal Coronary Angioplasty (Ptca), Cutting/Scoring | 1 | 0 |
| OFC | Catheter Introducer Kit | 1 | 1 |
| ONU | Drug-Eluting Peripheral Transluminal Angioplasty Catheter | 1 | 0 |
Plus 1 more product codes.
Review panels
- Cardiovascular (48)
Most recent Spectranetics Corp. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K250385 | Turbo-Elite Laser Atherectomy Catheter | MCW | 2025-03-13 | 30 |
| K223472 | TightRail Guardian Motorized Dilator Sheath, 9 French (575-009); TightRail Guardian Motorized Dilator Sheath, 11 French (575-011); TightRail Guardian Motorized Dilator Sheath, 13 French (575-013) | DRE | 2022-12-15 | 28 |
| K222837 | Turbo-Power (2.0mm) Laser Atherectomy Catheters, Turbo-Power (2.3mm) Laser Atherectomy Catheters | MCW | 2022-12-08 | 79 |
| K212784 | TightRail Guardian Motorized Dilator Sheath | DRE | 2022-08-24 | 357 |
| K203540 | Bridge Occlusion Balloon | MJN | 2020-12-23 | 20 |
| K180694 | Turbo-Power (2.0mm) Laser Atherectomy Catheters, Turbo-Power (2.3mm) Laser Atherectomy Catheters | MCW | 2018-04-05 | 20 |
| K172687 | Turbo-Power (2.0mm) Laser Atherectomy Catheters, Turbo-Power (2.3mm) Laser Atherectomy Catheters | MCW | 2017-11-27 | 82 |
| K170059 | Spectranetics Turbo-Elite Laser Atherectomy Catheters | MCW | 2017-04-07 | 91 |
| K162561 | Turbo-Power (2.0mm) Laser Atherectomy Catheters | MCW | 2017-01-05 | 113 |
| K161333 | TightRail Sub-C Rotating Dilator Sheath | DRE | 2016-07-08 | 57 |
33 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| DEN210024 | De Novo | Laser-Powered Inferior Vena Cava Filter Retrieval Catheter | 2021-12-21 |
| P160049 | PMA | STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON | 2017-07-26 |
| P050018 | PMA | ANGIOSCULPT SCORING BALLOON CATHETER | 2007-01-08 |
| P910001 | PMA | SPECTRANECTICS CVX-300 EXCIMER LASER SYSTEM | 1993-02-19 |
| P900032 | PMA | AIS EXIMER LASER ANGIOPLASTY | 1992-01-31 |
Recalls
21 product recalls in 18 recall events; 5 initiated in the last five years. Most recent: 2025-01-10.
2 product recalls in 2 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: AngioScore Inc. (2).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Spectranetics Corp. is the lead sponsor of 18 device studies on ClinicalTrials.gov (0 active or recruiting). Most recent:
- NCT05361967: Tack Optimized Balloon Angioplasty Post-Market Study (Terminated, started 2023-03-30)
- NCT03306199: TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions (Completed, started 2017-10-03)
- NCT03284229: Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD (Completed, started 2017-09-20)
- NCT03268018: ModificatiOn and Treatment of stenoseD Calcified inFrainguinal Lesions With Laser atherectomY in a Pilot Study (Completed, started 2017-06-07)
- NCT03175744: Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries (Suspended, started 2017-05-24)
Parent company SEC filings
KONINKLIJKE PHILIPS NV (PHG, RYLPF): EDGAR filings, CIK 313216. Caduvo groups Spectranetics Corp. under Philips; the parent's SEC registrant is entered by hand for the group, not matched by name.
FDA spellings included
FDA records this applicant under 5 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Spectranetics Corp. (27)
- Spectranetics, Inc. (17)
- Spectranetics Corporation (2)
- Spectranetics (1)
- The Spectranetics Corp. (1)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Spectranetics (Philips) (0 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Spectranetics Corp.?
FDA lists 43 510(k) clearances under 5 spellings of the applicant name “Spectranetics Corp.” (first 1999, latest 2025), plus 4 PMA and 1 De Novo decisions, across 11 product codes in 1 review panel. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Spectranetics Corp.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Spectranetics Corp. is 79 days. Since 2017: 79 days, versus 102 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Spectranetics Corp.?
The most frequent FDA product codes under this applicant name are DQY (Catheter, Percutaneous, 11); MCW (Catheter, Peripheral, Atherectomy, 10); DRE (Dilator, Vessel, For Percutaneous Catheterization, 9).
Next steps
- See all 43 Spectranetics Corp. clearances with predicates and recalls
- Run predicate analysis for product code DQY, Spectranetics Corp.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.